JPRN-UMIN000010265已完成未知
Preliminary trial of the increase of antihistamines in dose and a combination of different antihistamine on refractory spontaneous urticaria - Preliminary trial for the increase of antihistamines on refractory urticaria
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 32
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •A history of drug allergy. Pregnant or lactating. Glaucoma, hyper intraocular pressure or inferior urinary tract obstruction. Hyperthyroidism or any cardiovascular disease. Stegnotic gastrointestinal ulceration or pylorus stegnosis. Taking central nervous depressant, alcohol, MAO inhibitor or anti-choline agent. Disease that discourages from taking anti- cholinergic drugs or antihistamines. High renal or liver damage. Decreased cognitive ability or comprehension. Histories of taking anti-leukotriene or H2-blocker within two weeks before agreement. Histories of taking steroids by strongest class topical application or injection within four weeks before agreement. Occupation driving or operating machines. Any patients evaluated as inadequate by physicians.
研究者
相似试验
进行中（未招募）
Unknown
Investigating the effects of recommended - but unproven - therapies for anaphylaxis in a human histamine challenge modelISRCTN11335622Medical University of Vienna
进行中（未招募）
不适用
Efficacy and safety study of the antihistamine V0114CP 2.5mg in the treatment of seasonal allergic rhinitis randomized, double-blind, three arm parallel group study including placebo and active control arm (desloratadine 5 mg) - NDSeasonal allergic rhinitisMedDRA version: 9.1Level: LLTClassification code 10001723Term: Allergic rhinitisEUCTR2008-000133-22-ITPIERRE FABRE MEDICAMENT900
进行中（未招募）
1 期
Efficacy and safety study of the antihistamine V00114CP 2.5 mg in the treatment of seasonal allergic rhinitis. Randomised, double-blind, three arm parellel group study including placebo and active control arm (levocetirizine 5 mg).The medical condition to be investigated in the study is the seasonall allergic rhinitis. The intendent indication for the product is the treatment of the allergic rhinitis.EUCTR2008-008734-36-SKPIERRE FABRE MEDICAMENT900
已完成
4 期
Investigation of anti-histaminergic conditioning and expectation effects on the histamine prick-testPlacebo effectsT78.4Allergy, unspecifiedDRKS00026099niversitätsklinikum Essen (AöR), Klinik für Dermatologie, Venerologie und Allergologie101
已完成
不适用
Conditioning AntihistamineItch, conditioningJeuk, conditionerenNL-OMON27241eiden University92